These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 2121869

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Crucial role for interferon gamma in the synergism between tumor vasculature-targeted tumor necrosis factor alpha (NGR-TNF) and doxorubicin.
    Sacchi A, Gasparri A, Curnis F, Bellone M, Corti A.
    Cancer Res; 2004 Oct 01; 64(19):7150-5. PubMed ID: 15466213
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differential effects of human natural interferon-alpha and mismatched double-stranded RNA against a human renal cell carcinoma xenograft.
    Hubbell HR, Pequignot EC, Shanabrook KR, Carter WA, Williams RD, Strayer DR.
    Anticancer Res; 1990 Oct 01; 10(3):795-801. PubMed ID: 2369093
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Correlation of clinical and immunological parameters of metastatic renal cell carcinoma patients undergoing therapy with interleukin 2, interferon-alpha and retinoic acid.
    Elsässer-Beile U, Kölble N, Grussenmeyer T, Wetterauer U, Schultze-Seemann W.
    Anticancer Res; 1998 Oct 01; 18(3B):1883-90. PubMed ID: 9677439
    [Abstract] [Full Text] [Related]

  • 9. Myelopoiesis-associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma tumors: gamma interferon plus tumor necrosis factor alpha synergistically reduces immune suppressor and tumor growth-promoting activities of bone marrow cells and diminishes tumor recurrence and metastasis.
    Young MR, Wright MA.
    Cancer Res; 1992 Nov 15; 52(22):6335-40. PubMed ID: 1423279
    [Abstract] [Full Text] [Related]

  • 10. Differential sensitivity of renal cell carcinoma xenografts towards therapy with interferon-alpha, interferon-gamma, tumor necrosis factor and their combinations.
    Beniers AJ, van Moorselaar RJ, Peelen WP, Debruyne FM, Schalken JA.
    Urol Res; 1991 Nov 15; 19(2):91-8. PubMed ID: 1906659
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of alpha-difluoromethylornithine and recombinant interferon-alpha 2 on the growth of a human renal cell adenocarcinoma xenograft in nude mice.
    Heston WD, Fleischmann J, Tackett RE, Ratliff TL.
    Cancer Res; 1984 Aug 15; 44(8):3220-5. PubMed ID: 6430546
    [Abstract] [Full Text] [Related]

  • 13. The antitumor effects of IFN- beta against human renal cell carcinoma in athymic nude mice.
    Shirahama T, Kayajima T, Ohi Y.
    In Vivo; 1989 Aug 15; 3(5):345-9. PubMed ID: 2519876
    [Abstract] [Full Text] [Related]

  • 14. Synergistic antitumor effects of tumor necrosis factor and gamma-interferon on human colon carcinoma cell lines.
    Schiller JH, Bittner G, Storer B, Willson JK.
    Cancer Res; 1987 Jun 01; 47(11):2809-13. PubMed ID: 3105867
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Anti-proliferative effect of combined tumour necrosis factor-alpha and interferon-alpha on human pancreatic cancer in vitro and in vivo.
    Watanabe T, Fuchimoto S, Iwagaki H, Nonaka Y, Nezu M, Nishina T, Marutaka M, Susaki K, Naomoto Y, Shiki S.
    Anticancer Res; 1993 Jun 01; 13(5A):1501-5. PubMed ID: 8239528
    [Abstract] [Full Text] [Related]

  • 17. [Histopathologic evaluation of anti-tumor activity of alpha-interferon for renal cell carcinoma, especially in autoptic cases].
    Yamauchi T, Kawamura J, Yoshida O, Fukuyama T, Ogura K, Nakagawa K.
    Hinyokika Kiyo; 1985 Sep 01; 31(9):1539-52. PubMed ID: 4083212
    [Abstract] [Full Text] [Related]

  • 18. [Antitumor activity of UFT and interferon-alpha against human renal cell carcinoma in athymic nude mice].
    Yanase I, Shirahama T, Kayajima T, Ohi Y.
    Gan To Kagaku Ryoho; 1988 Apr 01; 15(4 Pt 1):709-12. PubMed ID: 3128184
    [Abstract] [Full Text] [Related]

  • 19. [Anti-tumour effect of UFT on human renal cell carcinoma heterotransplanted into nude mice].
    Onishi T, Machida T, Masuda F, Furuta M, Kondo I, Iizuka N, Suzuki M, Mori Y, Nakada J.
    Gan To Kagaku Ryoho; 1988 May 01; 15(5):1721-6. PubMed ID: 3130807
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic effects of monoclonal antibody G250, interferons and tumor necrosis factor, in mice with renal-cell carcinoma xenografts.
    van Dijk J, Uemura H, Beniers AJ, Peelen WP, Zegveld ST, Fleuren GJ, Warnaar SO, Oosterwijk E.
    Int J Cancer; 1994 Jan 15; 56(2):262-8. PubMed ID: 8314310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.